Prophylactic trials with implantable cardioverter defibrillators: MADIT and beyond

Journal of Interventional Cardiology

Volumn 11, Issue 3, 1998, Pages 227-233

  Nisam, Seah ^a,c   Singer, Igor ^b  

^a CPI/Guidant   (Belgium)

^b UNIVERSITY OF LOUISVILLE   (United States)

^c CPI/Guidant Europe   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; PROCAINAMIDE;

ARTICLE; CARDIOVERSION; CLINICAL TRIAL; DEFIBRILLATION; DRUG EFFICACY; HEART ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; META ANALYSIS; PRIMARY PREVENTION; PRIORITY JOURNAL;

EID: 0031776770     PISSN: 08964327     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8183.1998.tb00123.x     Document Type: Article

References (28)

1. Myerburg R, Kessler K, Castellanos A. Sudden cardiac death: Epidemiology, transient risk, and intervention assessment. Ann Intern Med 1993;119:1187-1197.
2. Pisa Z. Sudden death: A worldwide problem. In Kulbertus H, Wellens H, eds. Sudden Death, 3. The Hague/Boston/London, Martinus Hijhoff Publisher, 1980, pp. 237-247.
3. Myerburg R, Interian A, Mitrani R, et al. Frequency of sudden cardiac death and profiles of risk. Am J Cardiol 1997;80(5B):10F-19F.
4. Nisam S, Thomas A, Mover M, et al. Identifying patients for prophylactic automatic implantable cardioverter defibrillator therapy: Status of prospective studies. Am Heart J 1991;122:607-612.
5. Moss A, Hall J, Cannom D, et al., for the MADIT Investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk of ventricular arrhythmias. N Engl J Med 1996;335:1933-1940.
6. Moss A. Update on MADIT: The Multicenter Automatic Defibrillator Implantation Trial. Am J Cardiol 1997;79(6A):27-30.
7. Wilber D, Kall J, Kopp D. What can we expect from prophylactic implantable defibrillators. Am J Cardiol 1997; 80(5B):20-27.
8. Bigger JT, for the Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary artery bypass graft surgery. N Engl J Med 1997;337:1569-1575.
9. Bigger JT. Primary prevention of sudden cardiac death using implantable cardioverter-defibrillators. In Singer I, ed. Implantable Cardioverter-Defibrillator. Armonk, New York, Futura Publishing Company, Inc., 1994, pp. 515-546.
10. Kim S, Fisher J, Furman S, et al. Exacerbation of ventricular arrhythmias during the postoperative period after implantation of an automatic defibrillator. J Am Coll Cardiol 1991; 18:1200-1206.
11. Wever E, Hauer R, Van Capelle F, et al. Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors. Circulation 1995;91:2195-2203.
12. The Antiarrythmic Versus Implantabte Defibrillator (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997; 337:1576-1583.
13. Saksena S. On MADIT and future clinical trials for prevention of sudden cardiac death. J Interv Electrophysiol 1997;1:91-93.
14. Uretsky B, Sheahan R. Primary prevention of sudden cardiac death in heart failure: Will the solution be shocking? J Am Coll Cardiol 1997;30:1589-1597.
15. Bloch Thomsen PE. Nordic pilot study of the implantable cardioverter defibrillator in high-risk patients with an acute MI. Oral presentation during Europace, June 8-11, 1997, Athens, Greece.
16. Nademanee K. Sudden unexplained death syndrome in South-east Asia. Am J Cardiol 1997;79(6A):10-11.
17. Raviele A. Beta blocker strategy plus ICD trial. Oral presentation during 5th International Workshop on Cardiac Arrhythmias. Venice, Italy, Oct 7-10, 1997.
18. Hohnloser S. Macht MADIT weiter ICD-Studien bei Postinfarkt - Patienten überflussig oder notwendig? Oral presentation during Symposium "ICD-Therapie: Medizinischer Wandel und Gesundheitspolotische Wirklichkeit." Frankfurt, November 21, 1997.
19. Mirowski M, Mower M, Staewen W, et al. Standby automatic defibrillator. An approach to prevention of sudden coronary death. Arch Intern Med 1970;126:158-161.
20. Mower M, Hauser R. Historical development of the AICD. In Estes M, Manolis A, Wang P, eds. Implantable Cardioverter-Defibrillators. Marcel Decker, Inc., New York, 1994, pp. 173-186.
21. Saksena S, Madan N, Lewis C. Implantable cardioverter-defibrillators are preferable to drugs as primary therapy in sustained ventricular tachyarrhythmias. Prog Cardiovasc Dis 1996;38:445-454.
22. Böcker D, Block M, Borggrefe M, et al. Defibrillators are superior to antiarrhythmic drugs in the treatment of ventricular arrhythmias. Eur Heart J 1997;18:26-30.
23. Myerburg R, Castellanos A. Clinical trials of implantable defibrillators. N Engl J Med 1997;337:1621-1623.
24. Nisam S, Breithardt G. Mortality trials with implantable defibrillators. Am J Cardiol 1997;79:468-471.
25. Sweeney M, Ruskin J. Mortality benefits and the implantable cardioverter defibrillator. Circulation 1994;89:1851-1858.
26. Siebels J, Cappato R, Rüppel R, et al. Preliminary results of the Cardiac Arrest Study Hamburg (CASH). Am J Cardiol 1993;72:109F-113F.
27. Cappato R, Kuck K-H. "Study Results: Implantable heart defibrillator saves lives in patients with previous cardiac arrest." Press Release: March 30, 1998, during "Update on Clinical Trials" session at the 47th Annual Scientific Sessions of the American College of Cardiology, Atlanta, GA.
28. Connolly S. "Results of the Canadian Implantable Defibrillator Study (CIDS). Oral presentation during "Update on Clinical Trials" session at the 47th Annual Scientific Sessions of the American College of Cardiology, Atlanta, GA, March 30. 1998.